Dominik Karres

ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients

Andrew D.J. Pearson, Claudia Rössig, Giovanni Lesa et al. · European Journal of Cancer · 2020 · 68 citations · Full text

Medicine, Oncology, Pediatrics +17

Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents

Andrew D.J. Pearson, C. Michel Zwaan, E. Anders Kolb et al. · European Journal of Cancer · 2020 · 43 citations · Full text

Medicine, Pediatrics, Pharmacology +16

The EMA Review of Mylotarg (Gemtuzumab Ozogamicin) for the Treatment of Acute Myeloid Leukemia

Sahra Ali, Helen-Marie Dunmore, Dominik Karres et al. · The Oncologist · 2019 · 38 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Accelerating the Global Development of Pediatric Cancer Drugs: A Call to Coordinate the Submissions of Pediatric Investigation Plans and Pediatric Study Plans to the European Medicines Agency and US Food and Drug Administration

Gregory H. Reaman, Dominik Karres, Franca Ligas et al. · Journal of Clinical Oncology · 2020 · 36 citations · Full text

Medicine, Oncology, Pediatrics +15

The Critical Role of Academic Clinical Trials in Pediatric Cancer Drug Approvals: Design, Conduct, and Fit for Purpose Data for Positive Regulatory Decisions

Bram De Wilde, Elly Barry, Elizabeth Fox et al. · Journal of Clinical Oncology · 2022 · 20 citations · Full text

Pharmacy, Oncology, Pharmaceutical Policy +17